-
![]()
41
-
Invokana-Canagliflozin.pdf
- Invokana-CanagliflozinInvokana-CanagliflozinInvokana-Canagliflozin
-
-
![]()
12
-
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.pdf
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyCanagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyCanagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
-
-
![]()
14
-
Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.pdf
- Original2015Dustri-Verlag Dr. K. Feistle ISSN 0946-1965 DOI 10.5414/CP202158e-pub: November 19, 2014
-
-
![]()
51
-
SGLT2抑制剂canagliflozin的全合成研究.pdf
- Canagliflozin(9),化学名为 1-(β-D-吡喃葡萄糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯,是由强生公司开发的一种口服有效的选择性 C-糖苷类 SGLT2 抑制剂,疗效优于全球降糖药市场最畅销的药物西他列汀及另一种老药格列美脲。SGLT2主要分布在近曲小管的S1 段,负责重吸收肾小管液中90%的葡萄糖,通过阻断近曲小管对葡萄糖的重吸收使多余的糖从尿液中排出,从而达到降糖的目的。
-
-
![]()
37
-
canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via pparalpha in vivo and in vitro.[2020][life sci].pdf
- canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via pparalpha in vivo and in vitro.[2020][life sci]
-
-
![]()
145
-
SGLT2抑制剂canagliflozin的全合成研究.pdf
- SGLT2抑制剂canagliflozin的全合成研究
-
-
![]()
42
-
efficacy and safety of canagliflozin as add-on therapy to teneligliptin in japanese patients with type 2 diabetes mellitus_ results of a 24-week, rand.pdf
- efficacy and safety of canagliflozin as add-on therapy to teneligliptin in japanese patients with type 2 diabetes mellitus_ results of a 24-week, rand
-
-
![]()
108
-
canagliflozin Thomson Reuters cortellis-2016-02.pdf
- canagliflozin Thomson Reuters cortellis-2016-02canagliflozin Thomson Reuters cortellis-2016-02canagliflozin Thomson Reuters cortellis-2016-02
-
-
![]()
2
-
Canagliflozin_SGLT2的有效选择性抑制剂_842133-18-0_Apexbio.pdf
- 产品名:Canagliflozin 修订日期: 6/30/2016 产品说明书 化学性质 产品名: Canagliflozin Cas No.: 842133-18-0 分子量: 444.52 分子式
-
-
![]()
36
-
long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in japanese patients with type 2 diabetes.[2017][diabetes obes me.pdf
- long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in japanese patients with type 2 diabetes.[2017][diabetes obes me
-
向豆丁求助：有没有canagliflozin?
上海伟寰生物科技有..
